232 related articles for article (PubMed ID: 18388910)
1. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.
Dodge JC; Haidet AM; Yang W; Passini MA; Hester M; Clarke J; Roskelley EM; Treleaven CM; Rizo L; Martin H; Kim SH; Kaspar R; Taksir TV; Griffiths DA; Cheng SH; Shihabuddin LS; Kaspar BK
Mol Ther; 2008 Jun; 16(6):1056-64. PubMed ID: 18388910
[TBL] [Abstract][Full Text] [Related]
2. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.
Dodge JC; Treleaven CM; Fidler JA; Hester M; Haidet A; Handy C; Rao M; Eagle A; Matthews JC; Taksir TV; Cheng SH; Shihabuddin LS; Kaspar BK
Mol Ther; 2010 Dec; 18(12):2075-84. PubMed ID: 20859261
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
4. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
Franz CK; Federici T; Yang J; Backus C; Oh SS; Teng Q; Carlton E; Bishop KM; Gasmi M; Bartus RT; Feldman EL; Boulis NM
Neurobiol Dis; 2009 Mar; 33(3):473-81. PubMed ID: 19135533
[TBL] [Abstract][Full Text] [Related]
5. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
7. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
Kaspar BK; Lladó J; Sherkat N; Rothstein JD; Gage FH
Science; 2003 Aug; 301(5634):839-42. PubMed ID: 12907804
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of scAAV9-IGF1 extends survival in SOD1
Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
[TBL] [Abstract][Full Text] [Related]
9. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.
Henriques A; Pitzer C; Dittgen T; Klugmann M; Dupuis L; Schneider A
Mol Ther; 2011 Feb; 19(2):284-92. PubMed ID: 21139572
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for ALS delivers.
Boillée S; Cleveland DW
Trends Neurosci; 2004 May; 27(5):235-8. PubMed ID: 15111001
[TBL] [Abstract][Full Text] [Related]
11. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
12. Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis.
Steyn FJ; Ngo ST; Lee JD; Leong JW; Buckley AJ; Veldhuis JD; McCombe PA; Chen C; Bellingham MC
Endocrinology; 2012 Aug; 153(8):3735-46. PubMed ID: 22621959
[TBL] [Abstract][Full Text] [Related]
13. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice.
Ye P; Price W; Kassiotis G; Kollias G; D'Ercole AJ
J Neurosci Res; 2003 Mar; 71(5):721-31. PubMed ID: 12584730
[TBL] [Abstract][Full Text] [Related]
15. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
[TBL] [Abstract][Full Text] [Related]
17. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of amyotrophic lateral sclerosis as broad therapeutic targets for gene therapy applications utilizing adeno-associated viral vectors.
Merjane J; Chung R; Patani R; Lisowski L
Med Res Rev; 2023 Jul; 43(4):829-854. PubMed ID: 36786126
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study on the distribution of insulin-like growth factor I (IGF-I) receptor in the central nervous system of SOD1(G93A) mutant transgenic mice.
Chung YH; Joo KM; Shin CM; Lee YJ; Shin DH; Lee KH; Cha CI
Brain Res; 2003 Dec; 994(2):253-9. PubMed ID: 14642651
[TBL] [Abstract][Full Text] [Related]
20. The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse.
Saberi D; Ott B; Dahlke C; Matschke V; Schmitt-John T; Theiss C
J Neuropathol Exp Neurol; 2016 Apr; 75(4):347-57. PubMed ID: 26945034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]